• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Patente
  4. Humanes Clarazell-spezifisches Antigen und dessen Antikoerper SEC-41 sowie Hybridoma Han-41
 
  • Details
Options
Patent
Title

Humanes Clarazell-spezifisches Antigen und dessen Antikoerper SEC-41 sowie Hybridoma Han-41

Other Title
Human Clara cell-specific antigen and its antibody. SEC-41 and hybridoma Han-41
Abstract
The invention refers to the new monoclonal antibody SEC-41 and the hybridoma cell line Han-41, which produces this antibody and to the use of the antibody. The hybridoma cell line (DSM ACC2002) produces a monoclonal antibody which detects the glycoprotein, having a molecular weight of about 52,000 Daltons, in human broncho-alveolar lavage samples. Moreover, the monoclonal antibody according to the invention has an immunhistochemical reaction with type II pneumocytes and Clara cells of the adult human lung tissue. In addition, the monoclonal antibody (SEC-41) detects human lung epithelial cells in the female foetus of the 18th week of pregnancy.
Inventor(s)
Ochiai, A.
Emura, M.
Mohr, U.
Link to Espacenet
http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&locale=en_EP&FT=D&CC=DE&NR=4105374A
Patent Number
1991-4105374
Publication Date
1992
Language
German
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024